INTERNATIONAL PATENT: SHANGHAI GENERAL HOSPITAL, 上海市第一人民医院 FILES APPLICATION FOR "USE OF DOXORUBICIN-TETRAHEDRAL FRAMEWORK NUCLEIC ACID IN PREPARING DRUG FOR REDUCING ELECTRIC CONDUCTION RECURRENCE AFTER RADIO FREQUENCY CATHETER ABLATION"

GENEVA, Nov. 10 -- SHANGHAI GENERAL HOSPITAL (No.85 Wujin RoadHongkou District, Shanghai 200080), 上海市第一人民医院 (中国上海市虹口区武进路85号) filed a patent application (PCT/CN2025/090948) for "USE OF DOXORUBICIN-TETRAHEDRAL FRAMEWORK NUCLEIC ACID IN PREPARING DRUG FOR REDUCING ELECTRIC CONDUCTION RECURRENCE AFTER RADIO FREQUENCY CATHETER ABLATION" on Apr 24, 2025. With publication no. WO/2025/228231, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World I...